The present invention provides an improved method to deliver estrogen to menopausal women comprising administering ultra-low dose estradiol alternating with standard-dose estradiol.

 
Web www.patentalert.com

< Protease inhibitors

< Aminoalkylphosphonates and related compounds as edg receptor agonists

> 11beta-hydroxysteroid dehydrogenase type 1 active compounds

> Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
~ 00257